In the last decade, tranScrip has performed over £50m of innovative research, regulatory and post licensing support to over 250 clients. We have been integral to regulatory submissions, bringing on average one-two products to the market each year across a wide range of therapeutic areas.
The breadth of expertise and depth of experience in tranScrip allows efficient teams to be formed to provide support to contracts ranging from simple advice to coordinating large development programmes.
More than 50% of tranScrip’s work is for top 50 pharma but many of the truly innovative early projects are in academia and small biotechs.
Our unique position in the pharma environment
A leader in the rapidly growing Specialist Service Sector, we offer a variety of services, which until recently were largely covered by pharma “in-house”.
We provide strategic pre-clinical, medical, regulatory, drug safety and commercial services across the pharma value chain and support an array of activities, from discrete programmes conducted within the client’s organisation to provision of multifunctional teams that meet requirements of virtual pharma companies.
Hear tranScip's Managing Partner, Flic Gabbay, give an overview of the divergence and disruption in the pharma business model and explain tranScrip's position within it.
Our in-depth therapeutic, strategic and operational experience
We deliver strategic insights, innovative approaches and effective support across all aspects of drug development from early development and translational medicine through to registration and medical affairs, worldwide.
tranScrip’s teams form long-standing and successful partnerships with clients and through shared understanding, creative thinking and in-depth expertise, accomplish strategic goals and maximise opportunities throughout the drug development lifecycle.